FDA
approval
· 2016-11-07
FDA Approved: BONJESTA — Original Application (Duchesnay USA, Inc.)
Summary
FDA approved Bonjesta (doxylamine succinate and pyridoxine hydrochloride) in an original application as an extended-release fixed-dose combination for nausea an…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BONJESTA (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)